Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Kenneth Ataga, MD
Researcher Director
Division of Hematology/Oncology
University of Tennessee Health Science Center
956 Court Avenue
D324 Coleman Building
Memphis, Tennessee, United States
Dr. Ataga’s clinical interest is in classical hematology and hemoglobinopathies. He is the Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) at Memphis. His clinical research is focused on the vasculopathy of sickle cell disease, with an emphasis on pulmonary hypertension and renal complications, and coagulation activation in sickle cell disease. In addition, Dr. Ataga has a strong research interest in the development of new therapies for sickle cell disease. He conducts clinical trials in sickle cell disease funded by the National Institutes of Health and the Pharmaceutical Industry.
Representative Publications:
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Pharmacologic Therapies for Sickle Cell Disease
Related Content
-
Higher Prevalence of Hydroxyurea Use Is Associated with Lower Hospitalization Rate in a Population of Children with ...Background: Individuals with sickle cel...
-
Acute Care Utilization Is More Common in Patients with Sickle Cell Disease Who Have Chronic Complications and Chroni...Background: We undertook a large multisi...
-
Amy E. Sobota, MD, MPHAmy E. Sobota is a pediatric hematologis...
-
David Williams, MDDr. Williams is the president of Dana-Fa...
-
PCORI Board Approves $18 Million for Research on Sickle Cell DiseaseThe Patient-Centered Outcomes Research I...
-
High ED Utilization and Perceptions of Opioid Addictionhttps://www.youtube.com/watch?v=9xJ4VwtB...
-
Winthrop-University HospitalNYU Winthrop's pediatric hematologists p...